Seres Therapeutics
MCRB
#8745
Rank
โ‚ฌ0.12 B
Marketcap
0,67ย โ‚ฌ
Share price
-5.13%
Change (1 day)
-14.91%
Change (1 year)

Operating Margin for Seres Therapeutics (MCRB)

Operating Margin as of March 2025 (TTM): -97.34%

According to Seres Therapeutics's latest financial reports and stock price the company's current Operating Margin is -97.34%. At the end of 2023 the company had an Operating Margin of -90.02%.

Operating Margin history for Seres Therapeutics from 2016 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
2023-90.02%-97.43%
2022-3,509.50%7655.97%
2021-45.25%-83.14%
2020-268.33%31.74%
2019-203.68%-41.81%
2018-350.03%25.71%
2017-278.44%-33.82%
2016-420.74%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-179.45% 84.35%๐Ÿ‡บ๐Ÿ‡ธ USA
-226.57% 132.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-1,218.19% 1,151.48%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.